ID   TTF1_HUMAN              Reviewed;         905 AA.
AC   Q15361; A1L160; Q4VXF3; Q58EY2; Q6P5T5;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 3.
DT   28-JUN-2023, entry version 185.
DE   RecName: Full=Transcription termination factor 1;
DE            Short=TTF-1;
DE   AltName: Full=RNA polymerase I termination factor;
DE   AltName: Full=Transcription termination factor I;
DE            Short=TTF-I;
GN   Name=TTF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=7597036; DOI=10.1073/pnas.92.13.5827;
RA   Evers R., Grummt I.;
RT   "Molecular evolution of mammalian ribosomal gene terminator sequences and
RT   the transcription termination factor TTF-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:5827-5831(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-338 AND 457-905, AND VARIANT
RP   LYS-35.
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-403; SER-481 AND
RP   SER-487, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-476; SER-481 AND SER-487, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-487 AND SER-872, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-478; SER-481; SER-487 AND
RP   SER-872, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; THR-248; SER-403; SER-487
RP   AND SER-872, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-487 AND SER-872, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-700, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Multifunctional nucleolar protein that terminates ribosomal
CC       gene transcription, mediates replication fork arrest and regulates RNA
CC       polymerase I transcription on chromatin. Plays a dual role in rDNA
CC       regulation, being involved in both activation and silencing of rDNA
CC       transcription. Interaction with BAZ2A/TIP5 recovers DNA-binding
CC       activity. {ECO:0000250|UniProtKB:Q62187, ECO:0000269|PubMed:7597036}.
CC   -!- SUBUNIT: Oligomer. The oligomeric structure enables to interact
CC       simultaneously with two separate DNA fragments. Interacts with
CC       BAZ2A/TIP5. Interacts with CAVIN1. Interacts (via the N-terminal region
CC       (NRD) and a C-terminal region) with CDKN2A/ARF; the interaction is
CC       direct. Interacts (via C-terminal region) with NPM1/B23.
CC       {ECO:0000250|UniProtKB:Q62187}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q62187}. Nucleus,
CC       nucleolus {ECO:0000250|UniProtKB:Q62187}. Nucleus, nucleoplasm
CC       {ECO:0000250|UniProtKB:Q62187}. Note=May be localized to the nucleolus
CC       in an NPM1/B23-dependent manner. May be displaced from the nucleolus
CC       into the nucleoplasm in an CDKN2A/ARF-dependent manner. May shuttle
CC       back and forth from nucleoplasm to nucleolus.
CC       {ECO:0000250|UniProtKB:Q62187}.
CC   -!- DOMAIN: The N-terminal region (NRD) inhibits DNA-binding via its
CC       interaction with the C-terminal region. {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH62692.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAI04640.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAI27670.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=AAI27671.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=AAI43049.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=AAI43050.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=CAA58807.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA58807.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the C-terminal part.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X83973; CAA58807.1; ALT_SEQ; mRNA.
DR   EMBL; AL353701; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050734; AAH50734.1; -; mRNA.
DR   EMBL; BC062692; AAH62692.1; ALT_SEQ; mRNA.
DR   EMBL; BC104639; AAI04640.1; ALT_SEQ; mRNA.
DR   EMBL; BC127669; AAI27670.1; ALT_SEQ; mRNA.
DR   EMBL; BC127670; AAI27671.1; ALT_SEQ; mRNA.
DR   EMBL; BC143048; AAI43049.1; ALT_SEQ; mRNA.
DR   EMBL; BC143049; AAI43050.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS6948.1; -.
DR   PIR; I38182; I38182.
DR   RefSeq; NP_001192225.1; NM_001205296.1.
DR   RefSeq; NP_031370.2; NM_007344.3.
DR   RefSeq; XP_006717336.2; XM_006717273.3.
DR   AlphaFoldDB; Q15361; -.
DR   BioGRID; 113121; 118.
DR   IntAct; Q15361; 26.
DR   MINT; Q15361; -.
DR   STRING; 9606.ENSP00000333920; -.
DR   iPTMnet; Q15361; -.
DR   PhosphoSitePlus; Q15361; -.
DR   BioMuta; TTF1; -.
DR   DMDM; 158518534; -.
DR   EPD; Q15361; -.
DR   jPOST; Q15361; -.
DR   MassIVE; Q15361; -.
DR   MaxQB; Q15361; -.
DR   PaxDb; Q15361; -.
DR   PeptideAtlas; Q15361; -.
DR   ProteomicsDB; 60539; -.
DR   Antibodypedia; 45229; 263 antibodies from 32 providers.
DR   DNASU; 7270; -.
DR   Ensembl; ENST00000334270.3; ENSP00000333920.2; ENSG00000125482.13.
DR   GeneID; 7270; -.
DR   KEGG; hsa:7270; -.
DR   MANE-Select; ENST00000334270.3; ENSP00000333920.2; NM_007344.4; NP_031370.2.
DR   UCSC; uc004cbl.5; human.
DR   AGR; HGNC:12397; -.
DR   CTD; 7270; -.
DR   DisGeNET; 7270; -.
DR   GeneCards; TTF1; -.
DR   HGNC; HGNC:12397; TTF1.
DR   HPA; ENSG00000125482; Low tissue specificity.
DR   MIM; 600777; gene.
DR   neXtProt; NX_Q15361; -.
DR   OpenTargets; ENSG00000125482; -.
DR   PharmGKB; PA37062; -.
DR   VEuPathDB; HostDB:ENSG00000125482; -.
DR   eggNOG; KOG0051; Eukaryota.
DR   GeneTree; ENSGT00940000159729; -.
DR   HOGENOM; CLU_016962_1_0_1; -.
DR   InParanoid; Q15361; -.
DR   OMA; MQESRPA; -.
DR   OrthoDB; 457673at2759; -.
DR   PhylomeDB; Q15361; -.
DR   TreeFam; TF333537; -.
DR   PathwayCommons; Q15361; -.
DR   Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5683826; Surfactant metabolism.
DR   Reactome; R-HSA-73762; RNA Polymerase I Transcription Initiation.
DR   Reactome; R-HSA-73863; RNA Polymerase I Transcription Termination.
DR   SignaLink; Q15361; -.
DR   SIGNOR; Q15361; -.
DR   BioGRID-ORCS; 7270; 280 hits in 1177 CRISPR screens.
DR   ChiTaRS; TTF1; human.
DR   GeneWiki; Transcription_termination_factor,_RNA_polymerase_I; -.
DR   GenomeRNAi; 7270; -.
DR   Pharos; Q15361; Tbio.
DR   PRO; PR:Q15361; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q15361; protein.
DR   Bgee; ENSG00000125482; Expressed in buccal mucosa cell and 210 other tissues.
DR   ExpressionAtlas; Q15361; baseline and differential.
DR   Genevisible; Q15361; HS.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006353; P:DNA-templated transcription termination; NAS:UniProtKB.
DR   GO; GO:0008156; P:negative regulation of DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0006363; P:termination of RNA polymerase I transcription; IBA:GO_Central.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 1.
DR   InterPro; IPR001005; SANT/Myb.
DR   PANTHER; PTHR46760; TRANSCRIPTION TERMINATION FACTOR 1; 1.
DR   PANTHER; PTHR46760:SF1; TRANSCRIPTION TERMINATION FACTOR 1; 1.
DR   Pfam; PF13921; Myb_DNA-bind_6; 1.
DR   SMART; SM00717; SANT; 2.
DR   PROSITE; PS50090; MYB_LIKE; 2.
PE   1: Evidence at protein level;
KW   DNA replication inhibitor; DNA-binding; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Transcription termination; Ubl conjugation.
FT   CHAIN           1..905
FT                   /note="Transcription termination factor 1"
FT                   /id="PRO_0000250472"
FT   DOMAIN          612..661
FT                   /note="Myb-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00133"
FT   DOMAIN          661..745
FT                   /note="Myb-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00133"
FT   REGION          1..223
FT                   /note="N-terminal region (NRD)"
FT                   /evidence="ECO:0000250"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          151..443
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          498..886
FT                   /note="May be involved in interaction with ARF"
FT                   /evidence="ECO:0000250|UniProtKB:Q62187"
FT   COMPBIAS        1..17
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        172..191
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        246..260
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         65
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         240
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332"
FT   MOD_RES         248
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         403
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         476
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         478
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         481
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:21406692"
FT   MOD_RES         487
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         872
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   CROSSLNK        700
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         35
FT                   /note="E -> K (in dbSNP:rs11550314)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_027563"
FT   VARIANT         290
FT                   /note="A -> S (in dbSNP:rs8999)"
FT                   /id="VAR_027564"
FT   VARIANT         303
FT                   /note="V -> A (in dbSNP:rs3739914)"
FT                   /id="VAR_027565"
FT   VARIANT         360
FT                   /note="G -> V (in dbSNP:rs3739915)"
FT                   /id="VAR_027566"
FT   VARIANT         401
FT                   /note="R -> Q (in dbSNP:rs3739916)"
FT                   /id="VAR_027567"
FT   VARIANT         473
FT                   /note="E -> K (in dbSNP:rs12336746)"
FT                   /id="VAR_050201"
FT   VARIANT         885
FT                   /note="A -> V (in dbSNP:rs1752676)"
FT                   /id="VAR_061363"
FT   CONFLICT        281
FT                   /note="K -> T (in Ref. 3; AAH50734)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        649
FT                   /note="S -> R (in Ref. 1; CAA58807)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   905 AA;  103051 MW;  12F829CEFDDF96E8 CRC64;
     MEGESSRFEI HTPVSDKKKK KCSIHKERPQ KHSHEIFRDS SLVNEQSQIT RRKKRKKDFQ
     HLISSPLKKS RICDETANAT STLKKRKKRR YSALEVDEEA GVTVVLVDKE NINNTPKHFR
     KDVDVVCVDM SIEQKLPRKP KTDKFQVLAK SHAHKSEALH SKVREKKNKK HQRKAASWES
     QRARDTLPQS ESHQEESWLS VGPGGEITEL PASAHKNKSK KKKKKSSNRE YETLAMPEGS
     QAGREAGTDM QESQPTVGLD DETPQLLGPT HKKKSKKKKK KKSNHQEFEA LAMPEGSQVG
     SEVGADMQES RPAVGLHGET AGIPAPAYKN KSKKKKKKSN HQEFEAVAMP ESLESAYPEG
     SQVGSEVGTV EGSTALKGFK ESNSTKKKSK KRKLTSVKRA RVSGDDFSVP SKNSESTLFD
     SVEGDGAMME EGVKSRPRQK KTQACLASKH VQEAPRLEPA NEEHNVETAE DSEIRYLSAD
     SGDADDSDAD LGSAVKQLQE FIPNIKDRAT STIKRMYRDD LERFKEFKAQ GVAIKFGKFS
     VKENKQLEKN VEDFLALTGI ESADKLLYTD RYPEEKSVIT NLKRRYSFRL HIGRNIARPW
     KLIYYRAKKM FDVNNYKGRY SEGDTEKLKM YHSLLGNDWK TIGEMVARSS LSVALKFSQI
     SSQRNRGAWS KSETRKLIKA VEEVILKKMS PQELKEVDSK LQENPESCLS IVREKLYKGI
     SWVEVEAKVQ TRNWMQCKSK WTEILTKRMT NGRRIYYGMN ALRAKVSLIE RLYEINVEDT
     NEIDWEDLAS AIGDVPPSYV QTKFSRLKAV YVPFWQKKTF PEIIDYLYET TLPLLKEKLE
     KMMEKKGTKI QTPAAPKQVF PFRDIFYYED DSEGEDIEKE SEGQAPCMAH ACNSSTLGGQ
     GRWII
//
